Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
: Some medications have a small positive effect on reducing PTSD symptom severity and can be considered as potential monotherapy treatments; these include fluoxetine, paroxetine, sertraline, venlafaxine and quetiapine. Two medications, prazosin and risperidone, also have a small positive effect when used to augment pharmacological monotherapy. There was no evidence of superiority for one intervention over another in the small number of head-to-head comparison studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Psychopharmacological interventions are also effective evidence-based treatments for non-comorbid EDs, PTSD and related comorbid disorders, e.g., mood and anxiety disorders, but they should always be adjunctive to psychotherapeutic interventions for patients with ED + PTSD and related comorbidities (174–179) (see #9 in Figure 1).”
From The integrated treatment of eating disorders, posttraumatic stress disorder, and psychiatric comorbidity: a commentary on the evolution of principles and guidelines (2023) · cites this paper as [178]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052 · cited 1×
“It causes considerable distress and runs a chronic course in around a third of individuals (Kessler, Chiu, Demler, Merikangas, & Walters, 2005); keeping them off work, in receipt of long-term incapacity benefits and requiring support from medical services for many years (Ferry et al., 2008).”
BackgroundPosttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379 · cited 2×
“In conflict-afflicted areas, the prevalence is much higher, between 13% and 25% (Steel et al., 2009), and reaches more than 50% in survivors of sexual assault (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1996).”
BackgroundCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Steel, Z., Chey, T., Silove, D., Marnane, C., Bryant, R. A., & van Ommeren, M. (2009) · JAMA · doi:10.1001/jama.2009.1132 · Cited by 2,246 · cited 1×
“In conflict-afflicted areas, the prevalence is much higher, between 13% and 25% (Steel et al., 2009), and reaches more than 50% in survivors of sexual assault (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1996).”
BackgroundCONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72352 · Cited by 2,165
Wang, P. S., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Borges, G., Bromet, E. J., Bruffaerts, R., de Girolamo, G., de Graaf, R., Gureje, O., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61414-7 · Cited by 1,655 · cited 2×
“In addition to concerns about the tolerability and efficacy of TFPT, people with PTSD may live in areas of the world without access to it or, where they can access it, face long waiting lists for therapy, keeping them off work, in receipt of long-term incapacity benefits and requiring medical support (Wang et al., 200…”
BackgroundThe Maudsley Prescribing Guidelines in Psychiatry
Taylor, D. M., Barnes, T. R. E., & Young, A. H. (2021) · Wiley eBooks · doi:10.1002/9781119870203 · Cited by 988
Pietrzak, R. H., Goldstein, R. B., Southwick, S. M., & Grant, B. F. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.11.010 · Cited by 963 · cited 1×
“PTSD is also associated with high rates of debilitating comorbidities, with up to 50% suffering from depression (Pietrzak, Goldstein, Southwick, & Grant, 2011) and drug and alcohol abuse (Roberts, Kitchiner, Kenardy, & Bisson, 2010), and 19% will attempt suicide (Kessler et al., 1996).”
BackgroundPsychological therapies for chronic post-traumatic stress disorder (PTSD) in adults
Bisson, J. I., Roberts, N. P., Andrew, M., Cooper, R., & Lewis, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003388.pub4 · Cited by 829
Self-citationMcHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800 · cited 2×
“There are five studies that assess the use of topiramate for PTSD in the literature; Akuchekian et al., 2004 (McHugh et al., 2013), Batki et al., 2014(Review Manager (RevMan), 2014), Lindley et al., 2007 (Davidson et al., 2005), Tucker et al., 2007 (Matthew et al., 2011) and Yeh et al., 2010…”
BackgroundBrady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 690 · cited 2×
“…paroxetine (Marshall et al., 2001, 2007; SKB627 et al., unpublished; SKB650 et al., unpublished; Tucker et al., 2001), 11 assessed sertraline (Brady et al., 2000, 2005; Davidson, 2004; Davidson et al., 2006, 2001; Friedman et al., 2007; Li et al., 2017; Panahi et al., 2011; Pfizer588 –…”
InfluentialNonresponse and Dropout Rates in Outcome Studies on PTSD: Review and Methodological Considerations
Schottenbauer, M. A., Glass, C. R., Arnkoff, D. B., Tendick, V., & Gray, S. H. (2008) · Psychiatry: Interpersonal and Biological Processes · doi:10.1521/psyc.2008.71.2.134 · Cited by 634 · cited 2×
“(Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008), and TFPT is ineffective in nearly half of patients who are able to tolerate it (Schottenbauer et al., 2008); with higher PTSD severity predicting a poor response (Blanchard et al., 2003).”
BackgroundFeder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., aan het Rot, M., Lapidus, K. A. B., Wan, L.-B., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.62 · Cited by 613 · cited 2×
“, 2016) and 16 studies assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al., 2011; Rasmusson et al., 2017; Reist et al., 1989; Tucker et al., 2007; Y…”
Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A., Thompson, C. E., Dobie, D. J., Hoff, D., Rein, R. J., Straits-Tröster, K., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.371 · Cited by 607 · cited 7×
“Active drug PTSD symptoms Prazosin 10 studies (Ahmadpanah et al., 2014; Germain et al., 2012; Petrakis et al., 2016; Raskind et al., 2003; Raskind et al., 2007; Raskind et al., 2013; Raskind et al., 2018; Simpson et al., 2015; Taylor et al., 2008; Van Liempt et al., 2012), n = 652, SMD = −0.”
BackgroundMethodInfluentialRaskind, M. A., Peskind, E. R., Hoff, D. J., Hart, K. L., Holmes, H. A., Warren, D., Shofer, J., O’Connell, J., Taylor, F., Gross, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.032 · Cited by 552 · cited 5×
“Active drug PTSD symptoms Prazosin 10 studies (Ahmadpanah et al., 2014; Germain et al., 2012; Petrakis et al., 2016; Raskind et al., 2003; Raskind et al., 2007; Raskind et al., 2013; Raskind et al., 2018; Simpson et al., 2015; Taylor et al., 2008; Van Liempt et al., 2012), n = 652, SMD = −0.”
BackgroundMethodInfluentialDavidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470 · cited 3×
“…SKB627 et al., unpublished; SKB650 et al., unpublished; Tucker et al., 2001), 11 assessed sertraline (Brady et al., 2000, 2005; Davidson, 2004; Davidson et al., 2006, 2001; Friedman et al., 2007; Li et al., 2017; Panahi et al., 2011; Pfizer588 – sertraline; Tucker et al., 2003; Zohar et al.,…”
InfluentialEfficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1982 · Cited by 432 · cited 3×
“Active drug PTSD symptoms SSRIs Paroxetine Fluoxetine Sertraline Four studies (Marshall et al., 2001; Marshall et al., 2007; SKB627 et al., unpublished; Tucker et al., 2001), n = 1,122, SMD = −0.”
BackgroundMethodInfluentialPharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
Hoskins, M., Pearce, J., Bethell, A., Dankova, L., Barbui, C., Tol, W. A., van Ommeren, M., de Jong, J., Seedat, S., Chen, H., et al. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148551 · Cited by 418 · cited 2×
“We completed a review of pharmacological monotherapy in 2015 which found that paroxetine, fluoxetine, sertraline and venlafaxine could be effective for PTSD, but the magnitude of the effect was small and the clinical relevance was unclear (Hoskins et al., 2015).”
MethodSelf-citationFluoxetine in post‐traumatic stress disorder
Davidson, J., Roth, S., & Newman, E. (1991) · Journal of Traumatic Stress · doi:10.1002/jts.2490040309 · Cited by 412 · cited 4×
“There were 25 selective Serotonin Reuptake Inhibitor (SSRI) studies, of which seven assessed fluoxetine (Connor et al., 1999; Davidson et al., 2005; Hertzberg et al., 2000; Martenyi et al., 2007, 2002; van der Kolk et al., 1994, 2007), five assessed paroxetine (Marshall et al.”
BackgroundInfluentialvan der Kolk, B. A., Spinazzola, J., Blaustein, M. E., Hopper, J. W., Hopper, E. K., Korn, D. L., & Simpson, W. B. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0105 · Cited by 399 · cited 6×
“The use of medication in treating serious mental illnesses may often be suboptimal and efforts to improve this have included the use of prescribing algorithms (van der Kolk et al., 2007).”
BackgroundMethodInfluentialRaskind, M. A., Peterson, K., Williams, T., Hoff, D. J., Hart, K., Holmes, H., Homas, D., Hill, J., Daniels, C., Calohan, J., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081133 · Cited by 355 · cited 5×
“Active drug PTSD symptoms Prazosin 10 studies (Ahmadpanah et al., 2014; Germain et al., 2012; Petrakis et al., 2016; Raskind et al., 2003; Raskind et al., 2007; Raskind et al., 2013; Raskind et al., 2018; Simpson et al., 2015; Taylor et al., 2008; Van Liempt et al., 2012), n = 652, SMD = −0.”
BackgroundInfluentialFluoxetine in post-traumatic stress disorder: Randomised, double-blind study
Connor, K. M., Sutherland, S. M., Tupler, L. A., Malik, M. L., Jonathan, R., & Davidson, T. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.17 · Cited by 353
Treatment of Posttraumatic Stress Disorder With Amitriptyline and Placebo
Davidson, J. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150059010 · Cited by 350 · cited 1×
“…et al., 2001; Carey et al., 2012; Padala et al., 2006; Villarreal et al., 2016) and 16 studies assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994;…”
Stein, M. B., Kline, N. A., & Matloff, J. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1777 · Cited by 347 · cited 1×
“, 2015), olanzapine (Stein et al., 2002), pregabalin (Baniasadi et al.”
Trial of prazosin for post-traumatic stress disorder in military veterans
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1507598 · Cited by 342 · cited 5×
“Active drug PTSD symptoms Prazosin 10 studies (Ahmadpanah et al., 2014; Germain et al., 2012; Petrakis et al., 2016; Raskind et al., 2003; Raskind et al., 2007; Raskind et al., 2013; Raskind et al., 2018; Simpson et al., 2015; Taylor et al., 2008; Van Liempt et al., 2012), n = 652, SMD = −0.”
BackgroundInfluentialTaylor, F. B., Martin, P., Thompson, C., Williams, J., Mellman, T. A., Gross, C., Peskind, E. R., & Raskind, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.001 · Cited by 336 · cited 5×
“Active drug PTSD symptoms Prazosin 10 studies (Ahmadpanah et al., 2014; Germain et al., 2012; Petrakis et al., 2016; Raskind et al., 2003; Raskind et al., 2007; Raskind et al., 2013; Raskind et al., 2018; Simpson et al., 2015; Taylor et al., 2008; Van Liempt et al., 2012), n = 652, SMD = −0.”
BackgroundInfluentialTucker, P., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., & Pitts, C. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1105 · Cited by 324 · cited 4×
“SSRIs Paroxetine Fluoxetine Sertraline Four studies (Marshall et al., 2001; Marshall et al., 2007; SKB627 et al., unpublished; Tucker et al., 2001), n = 1,122, SMD = −0.”
BackgroundMethodInfluentialJetly, R., Heber, A., Fraser, G., & Boisvert, D. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.002 · Cited by 321 · cited 6×
“…(Pollack et al., 2011), guanfacine (Neylan et al., 2006), hydrocortisone (Ludascher et al., 2015), mirtazapine (Schneier et al., 2015), nabilone (Jetly et al., 2015), olanzapine (Stein et al., 2002), pregabalin (Baniasadi et al., 2014), sodium valproate (Hamner et al., 2009) and ziprasidone…”
BackgroundInfluentialA guide to guidelines for the treatment of PTSD and related conditions
Forbes, D., Creamer, M., Bisson, J. I., Cohen, J. A., Crow, B. E., Foa, E. B., Friedman, M. J., Keane, T. M., Kudler, H. S., & Ursano, R. J. (2010) · Journal of Traumatic Stress · doi:10.1002/jts.20565 · Cited by 307 · cited 1×
“Trauma-focused psychological therapies (TFPT) are the best evidenced and recommended first line of treatment for PTSD (Bisson, Roberts, Andrew, Cooper, & Lewis, 2013; Forbes et al., 2010).”
BackgroundSelf-citationShalev, A. Y. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.127 · Cited by 285 · cited 1×
“…11 assessed sertraline (Brady et al., 2000, 2005; Davidson, 2004; Davidson et al., 2006, 2001; Friedman et al., 2007; Li et al., 2017; Panahi et al., 2011; Pfizer588 – sertraline; Tucker et al., 2003; Zohar et al., 2002), and two assessed citalopram (Shalev et al., 2011; Tucker et al., 2003).”
BackgroundA preliminary study of lamotrigine for the treatment of posttraumatic stress disorder
Hertzberg, M. A., Butterfield, M. I., Feldman, M. E., Beckham, J. C., Sutherland, S. M., Connor, K. M., & Davidson, J. R. T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00011-6 · Cited by 271 · cited 3×
“…assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al., 2011; Rasmusson et al., 2017; Reist et al., 1989; Tucker et al., 2007;…”
Fluoxetine in posttraumatic stress disorder.
van der Kolk, B. A., Dreyfuss, D. A., Michaels, M. J., Shera, D., Berkowitz, R., Fisler, R. E., & Saxe, G. (1994) · PubMed · Cited by 244
Friedman, M. J., Marmar, C. R., Baker, D. G., Sikes, C. R., & Farfel, G. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0508 · Cited by 242 · cited 2×
“…n = 815, SMD = −0.29 (95% CI −0.55 to −0.03) I 2 = 46% Ten studies (Brady et al., 2000; Brady et al., 2005; Davidson et al., 2006; Davidson et al., 2001; Friedman et al., 2007; Li et al., 2017; Panahi et al., 2011; Pfizer588 – sertraline; Tucker et al., 2003; Zohar et al., 2002), n = 1,401, SMD =…”
BackgroundInfluentialPharmacotherapy for Posttraumatic Stress Disorder Using Phenelzine or Imipramine
KOSTEN, T. R., FRANK, J. B., DAN, E., McDOUGLE, C. J., & GILLER, E. L. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199106000-00011 · Cited by 238 · cited 7×
“The characteristics of the included studies (Davidson et al., 2006; Kosten et al., 1991; McRae et al., 2004; Petrakis et al., 2012; Saygin et al., 2002; Spivak et al., 2006; Tucker et al., 2003) are detailed in Table 5.”
BackgroundResultInfluentialGermain, A., Richardson, R., Moul, D. E., Mammen, O., Haas, G., Forman, S. D., Rode, N., Begley, A., & Nofzinger, E. A. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.11.010 · Cited by 229 · cited 3×
“…al., 2014; Akuchekian & Amanat, 2004; Attari et al., 2014; Baniasadi et al., 2014; Bartzokis et al., 2005; Batki et al., 2014; Becker et al., 2007; Germain et al., 2012; Golier et al 2012; Hamner et al., 2009, 2000; Heresco-Levy et al., 2002; Jetly et al., 2015; Krystal et al., 2011; Lindley et…”
BackgroundDavidson, J., Baldwin, D., Stein, D. J., Kuper, E., Benattia, I., Ahmed, S., Pedersen, R., & Musgnung, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1158 · Cited by 228 · cited 19×
“The characteristics of the included studies (Davidson et al., 2006; Kosten et al., 1991; McRae et al., 2004; Petrakis et al., 2012; Saygin et al., 2002; Spivak et al., 2006; Tucker et al., 2003) are detailed in Table 5.”
BackgroundMethodResultInfluential(1990) · PubMed · Cited by 222
Krystal, J. H., Rosenheck, R. A., Cramer, J. A., Vessicchio, J. C., Jones, K. M., Vertrees, J. E., Horney, R. A., Huang, G. D., Stock, C., & for the Veterans Affairs Cooperative Study No. 504 Group (2011) · JAMA · doi:10.1001/jama.2011.1080 · Cited by 220
A controlled trial of desipramine in 18 men with posttraumatic stress disorder
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.4.513 · Cited by 218 · cited 1×
“…agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al., 2011; Rasmusson et al., 2017; Reist et al., 1989; Tucker et al., 2007; Yeh et al., 2010).”
Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M., & Austin, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00013 · Cited by 218 · cited 15×
“The characteristics of the included studies (Davidson et al., 2006; Kosten et al., 1991; McRae et al., 2004; Petrakis et al., 2012; Saygin et al., 2002; Spivak et al., 2006; Tucker et al., 2003) are detailed in Table 5.”
BackgroundInfluentialFluoxetine Versus Placebo in Posttraumatic Stress Disorder
Martenyi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0305 · Cited by 215 · cited 1×
“…Serotonin Reuptake Inhibitor (SSRI) studies, of which seven assessed fluoxetine (Connor et al., 1999; Davidson et al., 2005; Hertzberg et al., 2000; Martenyi et al., 2007, 2002; van der Kolk et al., 1994, 2007), five assessed paroxetine (Marshall et al., 2001, 2007; SKB627 et al., unpublished;…”
Background(2013) · Diagnostic and Statistical Manual of Mental Disorders · doi:10.1176/appi.books.9780890425596.dsm05 · Cited by 210
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial
Davidson, J. R. T., Weisler, R. H., Butterfield, M. I., Casat, C. D., Connor, K. M., Barnett, S., & van Meter, S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01411-7 · Cited by 197 · cited 2×
“…et al., 2001; Carey et al., 2012; Padala et al., 2006; Villarreal et al., 2016) and 16 studies assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994;…”
Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder
Bartzokis, G., Lu, P. H., Turner, J., Mintz, J., & Saunders, C. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.039 · Cited by 182 · cited 5×
“Six studies assessed risperidone (Bartzokis et al., 2005; Hamner et al., 2000; Krystal et al., 2011; Monnelly et al., 2003; Reich et al., 2004; Rothbaum et al., 2008), three assessed topiramate (Akuchekian & Amanat, 2004; Batki et al., 2014; Lindley et al., 2007), and two assessed d-cycloserine…”
BackgroundInfluentialA controlled trial of phenelzine in posttraumatic stress disorder
Shestatzky, M., Greenberg, D., & Lerer, B. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90057-1 · Cited by 173 · cited 2×
“, 2006, 2006) and two assessed Monoamine Oxidase Inhibitors (MAOIs) (Baker et al., 1995; Kosten et al., 1991; Shestatzky et al., 1988).”
BackgroundPilot controlled trial of d-serine for the treatment of post-traumatic stress disorder
Heresco-Levy, U., Vass, A., Bloch, B., Wolosker, H., Dumin, E., Balan, L., Deutsch, L., & Kremer, I. (2009) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000339 · Cited by 169
Early psychological interventions to treat acute traumatic stress symptoms
Roberts, N. P., Kitchiner, N. J., Kenardy, J., & Bisson, J. I. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007944.pub2 · Cited by 167 · cited 2×
“This review used a common search strategy with the Cochrane review of early psychological interventions (Roberts et al., 2010).”
BackgroundMethodSelf-citationLow-Dose Risperidone as Adjunctive Therapy for Irritable Aggression in Posttraumatic Stress Disorder
Monnelly, E. P., Ciraulo, D. A., Knapp, C., & Keane, T. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00012 · Cited by 163 · cited 3×
“…2000; Heresco-Levy et al., 2002; Jetly et al., 2015; Krystal et al., 2011; Lindley et al., 2007; Ludascher et al., 2015; Manteghi et al., 2014; Monnelly et al., 2003; Naylor et al., 2015; Neylan et al., 2006; Petrakis et al., 2016; Pollack et al., 2011; Ramaswamy et al., 2016; Raskind et al.,…”
BackgroundHamner, M. B., Faldowski, R. A., Ulmer, H. G., Frueh, B. C., Huber, M. G., & Arana, G. W. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200301000-00001 · Cited by 162
Lack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans
Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Kudler, H. S., & Davidson, J. R. T. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009076231175 · Cited by 161 · cited 5×
“…2007; SKB627 et al., unpublished; Tucker et al., 2001), n = 1,122, SMD = −0.41 (95% CI −0.53 to −0.29) I 2 = 16% Five studies (Connor et al., 1999; Hertzberg et al., 2000; Martenyi et al., 2007; van der Kolk et al., 2007), n = 815, SMD = −0.29 (95% CI −0.55 to −0.03) I 2 = 46% Ten studies…”
BackgroundInfluentialOlanzapine in the treatment of post-traumatic stress disorder: a pilot study
Butterfield, M. I., Becker, M. E., Connor, K. M., Sutherland, S., Churchill, L. E., & Davidson, J. R. T. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200107000-00003 · Cited by 160 · cited 11×
“Every study described itself as randomised, but only nine studies adequately described the method of random sequence generation and seven adequately described the method of allocation concealment and were deemed Four studies (Marshall et al., 2001; Marshall et al., 2007; SKB627 et al., unpublished; Tucker et al., 2001…”
BackgroundInfluentialDavidson, J., Rothbaum, B. O., Tucker, P., Asnis, G., Benattia, I., & Musgnung, J. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222514.71390.c1 · Cited by 157 · cited 12×
“The characteristics of the included studies (Davidson et al., 2006; Kosten et al., 1991; McRae et al., 2004; Petrakis et al., 2012; Saygin et al., 2002; Spivak et al., 2006; Tucker et al., 2003) are detailed in Table 5.”
BackgroundMethodResultInfluentialSertraline in the Treatment of Co‐occurring Alcohol Dependence and Posttraumatic Stress Disorder
Brady, K. T., Sonne, S., Anton, R. F., Randall, C. L., Back, S. E., & Simpson, K. (2005) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000156129.98265.57 · Cited by 150
Cipriani, A., Williams, T., Nikolakopoulou, A., Salanti, G., Chaimani, A., Ipser, J., Cowen, P. J., Geddes, J. R., & Stein, D. J. (2018) · Psychological Medicine · doi:10.1017/s003329171700349x · Cited by 149 · cited 1×
“A recent network meta-analysis (NMA) by Cipriani and colleagues (Cipriani et al., 2018), which collated monotherapy versus placebo, augmentation and drug-versus-drug studies, provided evidence of superiority over placebo for phenelzine, desipramine, paroxetine, venlafaxine, fluoxetine, risperidone and sertraline in de…”
ResultAugmentation therapies for treatment-resistant depression: systematic review and meta-analysis
Strawbridge, R., Carter, B., Marwood, L., Bandelow, B., Tsapekos, D., Nikolova, V. L., Taylor, R., Mantingh, T., de Angel, V., Patrick, F., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.233 · Cited by 140 · cited 1×
“…one medication, and then adding in a second medication to hopefully improve the clinical outcome, is a common strategy in other serious mental health conditions (Strawbridge, Carter, Marwood, & Bandelow, 2019) and a logical next step for people with PTSD who have not responded to monotherapy alone.”
BackgroundPetrakis, I. L., Ralevski, E., Desai, N., Trevisan, L. A., Gueorguieva, R. V., Rounsaville, B. J., & Krystal, J. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.283 · Cited by 134 · cited 3×
“The characteristics of the included studies (Davidson et al., 2006; Kosten et al., 1991; McRae et al., 2004; Petrakis et al., 2012; Saygin et al., 2002; Spivak et al., 2006; Tucker et al., 2003) are detailed in Table 5.”
BackgroundPilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder
Heresco-Levy, U., Kremer, I., Javitt, D. C., Goichman, R., Reshef, A., Blanaru, M., & Cohen, T. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003061 · Cited by 134 · cited 2×
“…et al., 2014; Bartzokis et al., 2005; Batki et al., 2014; Becker et al., 2007; Germain et al., 2012; Golier et al 2012; Hamner et al., 2009, 2000; Heresco-Levy et al., 2002; Jetly et al., 2015; Krystal et al., 2011; Lindley et al., 2007; Ludascher et al., 2015; Manteghi et al., 2014; Monnelly et…”
BackgroundTucker, P., Trautman, R. P., Wyatt, D. B., Thompson, J., Wu, S.-C., Capece, J. A., & Rosenthal, N. R. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0204 · Cited by 122 · cited 5×
“Every study described itself as randomised, but only nine studies adequately described the method of random sequence generation and seven adequately described the method of allocation concealment and were deemed Four studies (Marshall et al., 2001; Marshall et al., 2007; SKB627 et al., unpublished; Tucker et al., 2001…”
BackgroundInfluentialBaker, D. G., Diamond, B. I., Gillette, G. M., Hamner, M. B., Katzelnick, D. J., Keller, T., Mellman, T. A., Pontius, E., Rosenthal, M., Tucker, P. M., et al. (1995) · Psychopharmacology · doi:10.1007/bf02246271 · Cited by 121 · cited 3×
“Every study described itself as randomised, but only nine studies adequately described the method of random sequence generation and seven adequately described the method of allocation concealment and were deemed Four studies (Marshall et al., 2001; Marshall et al., 2007; SKB627 et al., unpublished; Tucker et al., 2001…”
BackgroundInfluentialReich, D. B., Winternitz, S., Hennen, J., Watts, T., & Stanculescu, C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1204 · Cited by 119 · cited 5×
“Six studies assessed risperidone (Bartzokis et al., 2005; Hamner et al., 2000; Krystal et al., 2011; Monnelly et al., 2003; Reich et al., 2004; Rothbaum et al., 2008), three assessed topiramate (Akuchekian & Amanat, 2004; Batki et al., 2014; Lindley et al., 2007), and two assessed d-cycloserine…”
BackgroundInfluentialForman-Hoffman, V., Cook Middleton, J., Feltner, C., Gaynes, B. N., Palmieri Weber, R., Bann, C., Viswanathan, M., Lohr, K. N., Baker, C., & Green, J. (2018) · doi:10.23970/ahrqepccer207 · Cited by 116 · cited 2×
“We are not aware of any reviews that have explored the evidence-base for strict augmentation strategies in PTSD, favouring instead to combine monotherapy and augmentation randomised controlled trials for the same medication (Forman-Hoffman et al., 2018a).”
BackgroundPetrakis, I. L., Desai, N., Gueorguieva, R., Arias, A., O'Brien, E., Jane, J. S., Sevarino, K., Southwick, S., & Ralevski, E. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12926 · Cited by 115 · cited 4×
“…et al., 2011; Lindley et al., 2007; Ludascher et al., 2015; Manteghi et al., 2014; Monnelly et al., 2003; Naylor et al., 2015; Neylan et al., 2006; Petrakis et al., 2016; Pollack et al., 2011; Ramaswamy et al., 2016; Raskind et al., 2018, 2007, 2003, 2013; Reich et al., 2004; Rothbaum et al.,…”
BackgroundInfluentialVillarreal, G., Hamner, M. B., Cañive, J. M., Robert, S., Calais, L. A., Durklaski, V., Zhai, Y., & Qualls, C. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15070967 · Cited by 112 · cited 6×
“In comparison to our previous review, three new studies are notable for their impact and innovation; Li et al. (2017), Villarreal et al. (2016) and Feder et al. (2014).”
BackgroundResultInfluentialThe Efficacy and Tolerability of Tiagabine in Adult Patients With Post-Traumatic Stress Disorder
Davidson, J. R. T., Brady, K., Mellman, T. A., Stein, M. B., & Pollack, M. H. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e5115 · Cited by 108 · cited 1×
“…et al., 2001; Carey et al., 2012; Padala et al., 2006; Villarreal et al., 2016) and 16 studies assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994;…”
The Maudsley Prescribing Guidelines in Psychiatry, 12th ed
Jenkins, J. A., & Kontos, N. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16bk10716 · Cited by 107 · cited 2×
“The recognised side effects from prazosin include hypotension (especially severe first-dose hypotension), syncope, drowsiness, dizziness, asthenia and depression, and particular caution is required for patients with a history of hypotension or micturition syncope (Taylor, Barnes, & Young, 2018).”
BackgroundNo Improvement of Posttraumatic Stress Disorder Symptoms With Guanfacine Treatment
Neylan, T. C., Lenoci, M., Samuelson, K. W., Metzler, T. J., Henn-Haase, C., Hierholzer, R. W., Lindley, S. E., Otte, C., Schoenfeld, F. B., Yesavage, J. A., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2186 · Cited by 104 · cited 4×
“, 2011), guanfacine (Neylan et al., 2006), hydrocortisone (Ludascher et al.”
BackgroundInfluentialPharmacotherapy of post‐traumatic stress disorder with a novel psychotropic
Katz, R. J., Lott, M. H., Arbus, P., Crocq, L., Herlobsen, P., Lingjaerde, O., Lopez, G., Loughrey, G. C., Macfarlane, D. J., McIvor, R., et al. (1994) · Anxiety · doi:10.1002/anxi.3070010404 · Cited by 101 · cited 9×
“, 2016) and 16 studies assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al., 2011; Rasmusson et al., 2017; Reist et al., 1989; Tucker et al., 2007; Y…”
BackgroundMethodInfluentialDavis, L. L., Davidson, J. R. T., Ward, L. C., Bartolucci, A., Bowden, C. L., & Petty, F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160f83b · Cited by 101 · cited 1×
“…2012; Padala et al., 2006; Villarreal et al., 2016) and 16 studies assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al.,…”
Pollack, M. H., Hoge, E. A., Worthington, J. J., Moshier, S. J., Wechsler, R. S., Brandes, M., & Simon, N. M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05607gry · Cited by 101
Padala, P. R., Madison, J., Monnahan, M., Marcil, W., Price, P., Ramaswamy, S., Din, A. U., Wilson, D. R., & Petty, F. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00005 · Cited by 99 · cited 4×
“Four studies assessed antipsychotic medications (Butterfield et al., 2001; Carey et al., 2012; Padala et al., 2006; Villarreal et al., 2016) and 16 studies assessed other agents (Braun et al.”
BackgroundInfluentialMarshall, R. D., Lewis-Fernandez, R., Blanco, C., Simpson, H. B., Lin, S.-H., Vermes, D., Garcia, W., Schneier, F., Neria, Y., Sanchez-Lacay, A., et al. (2007) · Depression and Anxiety · doi:10.1002/da.20176 · Cited by 98
The Role of Criterion A2 in the DSM-IV Diagnosis of Posttraumatic Stress Disorder
Karam, E. G., Andrews, G., Bromet, E., Petukhova, M., Ruscio, A. M., Salamoun, M., Sampson, N., Stein, D. J., Alonso, J., Andrade, L. H., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.032 · Cited by 97 · cited 1×
“Across the world, there is an estimated 12-month prevalence of 3–4% (Karam et al., 2009).”
BackgroundDunlop, B. W., Binder, E. B., Iosifescu, D., Mathew, S. J., Neylan, T. C., Pape, J. C., Carrillo-Roa, T., Green, C., Kinkead, B., Grigoriadis, D., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.024 · Cited by 96 · cited 4×
“…Villarreal et al., 2016) and 16 studies assessed other agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al., 2011; Rasmusson et al., 2017;…”
BackgroundInfluentialRothbaum, B. O., Killeen, T. K., Davidson, J. R. T., Brady, K. T., Connor, K. M., & Heekin, M. H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0402 · Cited by 94
Simpson, T. L., Malte, C. A., Dietel, B., Tell, D., Pocock, I., Lyons, R., Varon, D., Raskind, M., & Saxon, A. J. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12703 · Cited by 94 · cited 4×
“…Petrie, & Radant, 2003; Raskind et al., 2013; Reich, Winternitz, Hennen, Watts, & Stanculescu, 2004; Rothbaum et al., 2008; Schneier et al., 2015; Simpson et al., 2015; Stein, Kline, & Matloff, 2002; Taylor et al., 2008; Zohar et al., 2002) included for our systematic review of augmentation…”
BackgroundInfluentialBuhmann, C. B., Nordentoft, M., Ekstroem, M., Carlsson, J., & Mortensen, E. L. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150961 · Cited by 92
Batki, S. L., Pennington, D. L., Lasher, B., Neylan, T. C., Metzler, T., Waldrop, A., Delucchi, K., & Herbst, E. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12496 · Cited by 91 · cited 7×
“Six studies assessed risperidone (Bartzokis et al., 2005; Hamner et al., 2000; Krystal et al., 2011; Monnelly et al., 2003; Reich et al., 2004; Rothbaum et al., 2008), three assessed topiramate (Akuchekian & Amanat, 2004; Batki et al., 2014; Lindley et al., 2007), and two assessed d-cycloserine (Attari et al., 2014; H…”
BackgroundInfluentialA Placebo-Controlled Trial of Bupropion SR in the Treatment of Chronic Posttraumatic Stress Disorder
Becker, M. E., Hertzberg, M. A., Moore, S. D., Dennis, M. F., Bukenya, D. S., & Beckham, J. C. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318032eaed · Cited by 84
Ahmadpanah, M., Sabzeiee, P., Hosseini, S. M., Torabian, S., Haghighi, M., Jahangard, L., Bajoghli, H., Holsboer-Trachsler, E., & Brand, S. (2014) · Neuropsychobiology · doi:10.1159/000362243 · Cited by 79 · cited 3×
“The characteristics of the 34 included studies (Ahmadpanah et al., 2014; Akuchekian & Amanat, 2004; Attari et al., 2014; Baniasadi et al., 2014; Bartzokis et al., 2005; Batki et al., 2014; Becker et al., 2007; Germain et al., 2012; Golier et al 2012; Hamner et al., 2009, 2000; Heresco-Levy et al.,…”
BackgroundMethodLindley, S. E., Carlson, E. B., & Hill, K. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a43ee · Cited by 77 · cited 4×
“…115 studies were included for our series of pharmacological reviews (Figure 1); with Jetly, Heber, Fraser, & Boisvert, 2015; Krystal et al., 2011; Lindley, Carlson, & Hill, 2007; Ludascher et al., 2015; Manteghi, Hebrani, Mortezania, Haghighi, & Javanbakht, 2014; Monnelly, Ciraulo, Knapp, &…”
BackgroundInfluentialPopiel, A., Zawadzki, B., Pragłowska, E., & Teichman, Y. (2015) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2015.01.002 · Cited by 77
Davis, L. L., Jewell, M. E., Ambrose, S., Farley, J., English, B., Bartolucci, A., & Petty, F. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125685.82219.1a · Cited by 73 · cited 2×
“The use of nefazodone as a comparator in two studies (McRae et al., 2004; Saygin et al., 2002) is curious; nefazodone was first marketed in 1994 and there has been only one other PTSD RCT (Davis et al., 2004), where it was compared to placebo and failed to demonstrate efficacy.”
MethodCarey, P., Suliman, S., Ganesan, K., Seedat, S., & Stein, D. J. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2238 · Cited by 70 · cited 4×
“Four studies assessed antipsychotic medications (Butterfield et al., 2001; Carey et al., 2012; Padala et al., 2006; Villarreal et al., 2016) and 16 studies assessed other agents (Braun et al.”
BackgroundInfluentialA randomized controlled trial of ganaxolone in posttraumatic stress disorder
Rasmusson, A. M., Marx, C. E., Jain, S., Farfel, G. M., Tsai, J., Sun, X., Geracioti, T. D., Hamner, M. B., Lohr, J. B., Rosse, R. B., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4649-y · Cited by 69 · cited 3×
“…agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al., 2011; Rasmusson et al., 2017; Reist et al., 1989; Tucker et al., 2007; Yeh et al., 2010).”
Martenyi, F., Brown, E. B., & Caldwell, C. D. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31803308ce · Cited by 68 · cited 3×
“…unpublished; Tucker et al., 2001), n = 1,122, SMD = −0.41 (95% CI −0.53 to −0.29) I 2 = 16% Five studies (Connor et al., 1999; Hertzberg et al., 2000; Martenyi et al., 2007; van der Kolk et al., 2007), n = 815, SMD = −0.29 (95% CI −0.55 to −0.03) I 2 = 46% Ten studies (Brady et al., 2000; Brady…”
BackgroundInfluentialYeh, M. S. L., Mari, J. J., Costa, M. C. P., Andreoli, S. B., Bressan, R. A., & Mello, M. F. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00188.x · Cited by 63 · cited 3×
“04) Other drugs Topiramate Two studies (Tucker et al., 2007; Yeh et al., 2010), n = 69, SMD = −0.”
BackgroundSchneier, F. R., Campeas, R., Carcamo, J., Glass, A., Lewis-Fernandez, R., Neria, Y., Sanchez-Lacay, A., Vermes, D., & Wall, M. M. (2015) · Depression and Anxiety · doi:10.1002/da.22384 · Cited by 61 · cited 4×
“…(Becker et al., 2007), eszopiclone (Pollack et al., 2011), guanfacine (Neylan et al., 2006), hydrocortisone (Ludascher et al., 2015), mirtazapine (Schneier et al., 2015), nabilone (Jetly et al., 2015), olanzapine (Stein et al., 2002), pregabalin (Baniasadi et al., 2014), sodium valproate (Hamner…”
BackgroundInfluentialComparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder
McRae, A. L., Brady, K. T., Mellman, T. A., Sonne, S. C., Killeen, T. K., Timmerman, M. A., & Bayles-Dazet, W. (2004) · Depression and Anxiety · doi:10.1002/da.20008 · Cited by 60 · cited 7×
“The characteristics of the included studies (Davidson et al., 2006; Kosten et al., 1991; McRae et al., 2004; Petrakis et al., 2012; Saygin et al., 2002; Spivak et al., 2006; Tucker et al., 2003) are detailed in Table 5.”
BackgroundMethodResultInfluentialKwako, L. E., George, D. T., Schwandt, M. L., Spagnolo, P. A., Momenan, R., Hommer, D. W., Diamond, C. A., Sinha, R., Shaham, Y., & Heilig, M. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3665-4 · Cited by 58 · cited 3×
“…agents (Braun et al., 1991; Davidson et al., 2007, 1990, 2003; Davis et al., 2008, 2004; Dunlop et al., 2017; Feder et al., 2014; Hertzberg et al., 1999; Katz et al., 1994; Kwako et al., 2015; Matthew et al., 2011; Rasmusson et al., 2017; Reist et al., 1989; Tucker et al., 2007; Yeh et al., 2010).”
Mathew, S. J., Vythilingam, M., Murrough, J. W., Zarate, C. A., Feder, A., Luckenbaugh, D. A., Kinkead, B., Parides, M. K., Trist, D. G., Bani, M. S., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.012 · Cited by 55 · cited 6×
“This review did not find evidence to recommend the use of topiramate augmentation, in contrast with other reviews (Matthew et al., 2011), for several reasons; we have delineated monotherapy and augmentation studies and excluded studies from the quantitative analysis that suffered from a lack of…”
BackgroundResultInfluentialJerud, A. B., Pruitt, L. D., Zoellner, L. A., & Feeny, N. C. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.12.002 · Cited by 55 · cited 2×
“Two of the studies (Buhmann et al., 2016; Jerud et al., 2016) assessed sertraline versus a flexible therapeutic approach and prolonged exposure, respectively.”
BackgroundDavidson, J. R. T., Connor, K. M., Hertzberg, M. A., Weisler, R. H., Wilson, W. H., & Payne, V. M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155817.21467.6c · Cited by 54 · cited 3×
“There were 25 selective Serotonin Reuptake Inhibitor (SSRI) studies, of which seven assessed fluoxetine (Connor et al., 1999; Davidson et al., 2005; Hertzberg et al., 2000; Martenyi et al., 2007, 2002; van der Kolk et al., 1994, 2007), five assessed paroxetine (Marshall et al.”
BackgroundA preliminary controlled trial of divalproex in posttraumatic stress disorder.
Hamner, M. B., Faldowski, R. A., Robert, S., et al. (2009) · PubMed · Cited by 49
Tucker, P., MD, Potter-Kimball, R., RN, MS, Wyatt, D. B., RN, Parker, D. E., PhD, Burgin, C., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4179 · Cited by 49
A Preliminary Controlled trial of Divalproex in Posttraumatic Stress Disorder
Hamner, M. B., Faldowski, R. A., Ulmer, H. G., Horner, M. D., & Lorberbaum, J. P. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100205 · Cited by 49 · cited 2×
“…guanfacine (Neylan et al., 2006), hydrocortisone (Ludascher et al., 2015), mirtazapine (Schneier et al., 2015), nabilone (Jetly et al., 2015), olanzapine (Stein et al., 2002), pregabalin (Baniasadi et al., 2014), sodium valproate (Hamner et al., 2009) and ziprasidone (Ramaswamy et al., 2016).”
BackgroundA Pilot Study of Mifepristone in Combat-Related PTSD
Golier, J. A., Caramanica, K., DeMaria, R., & Yehuda, R. (2012) · Depression Research and Treatment · doi:10.1155/2012/393251 · Cited by 48 · cited 1×
“…& Amanat, 2004; Attari et al., 2014; Baniasadi et al., 2014; Bartzokis et al., 2005; Batki et al., 2014; Becker et al., 2007; Germain et al., 2012; Golier et al 2012; Hamner et al., 2009, 2000; Heresco-Levy et al., 2002; Jetly et al., 2015; Krystal et al., 2011; Lindley et al., 2007; Ludascher et…”
Prediction of response to psychological treatment among motor vehicle accident survivors with PTSD
Blanchard, E. B., Hickling, E. J., Malta, L. S., Jaccard, J. J., Devineni, T., Veazey, C. H., & Galovski, T. E. (2003) · Behavior Therapy · doi:10.1016/s0005-7894(03)80005-9 · Cited by 43 · cited 2×
“(Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008), and TFPT is ineffective in nearly half of patients who are able to tolerate it (Schottenbauer et al., 2008); with higher PTSD severity predicting a poor response (Blanchard et al., 2003).”
BackgroundFrommberger, U., Stieglitz, R.-D., Nyberg, E., Richter, H., Novelli-Fischer, U., Angenendt, J., Zaninelli, R., & Berger, M. (2004) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500310004803 · Cited by 42
Panahi, Y., Moghaddam, B. R., Sahebkar, A., Nazari, M. A., Beiraghdar, F., Karami, G., & Saadat, A. R. (2011) · Psychological Medicine · doi:10.1017/s0033291711000201 · Cited by 41 · cited 5×
“…al., 2001), 11 assessed sertraline (Brady et al., 2000, 2005; Davidson, 2004; Davidson et al., 2006, 2001; Friedman et al., 2007; Li et al., 2017; Panahi et al., 2011; Pfizer588 – sertraline; Tucker et al., 2003; Zohar et al., 2002), and two assessed citalopram (Shalev et al., 2011; Tucker et…”
BackgroundInfluentialDavidson, J. R. T. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00005 · Cited by 39 · cited 3×
“, 2001), 11 assessed sertraline (Brady et al., 2000, 2005; Davidson, 2004; Davidson et al., 2006, 2001; Friedman et al., 2007; Li et al., 2017; Panahi et al., 2011; Pfizer588 – sertraline; Tucker et al., 2003; Zohar et al., 2002), and two assessed citalopram (Shalev et al.”
Backgroundbaniasadi, M., Hosseini, G., Bordbar, M. R. F., Ardanı, A. R., & Toroghi, H. M. (2014) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000456590.12998.41 · Cited by 37 · cited 3×
“, 2002), pregabalin (Baniasadi et al., 2014), sodium valproate (Hamner et al.”
BackgroundLudäscher, P., Schmahl, C., Feldmann, R. E., Kleindienst, N., Schneider, M., & Bohus, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115592339 · Cited by 35
Naylor, J. C., Kilts, J. D., Bradford, D. W., Strauss, J. L., Capehart, B. P., Szabo, S. T., Smith, K. D., Dunn, C. E., Conner, K. M., Davidson, J. R. T., et al. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000061 · Cited by 33 · cited 4×
“…et al., 2002; Jetly et al., 2015; Krystal et al., 2011; Lindley et al., 2007; Ludascher et al., 2015; Manteghi et al., 2014; Monnelly et al., 2003; Naylor et al., 2015; Neylan et al., 2006; Petrakis et al., 2016; Pollack et al., 2011; Ramaswamy et al., 2016; Raskind et al., 2018, 2007, 2003,…”
BackgroundInfluentialSpivak, B., Strous, R. D., Shaked, G., Shabash, E., Kotler, M., & Weizman, A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203195.65710.f0 · Cited by 33 · cited 2×
“The characteristics of the included studies (Davidson et al., 2006; Kosten et al., 1991; McRae et al., 2004; Petrakis et al., 2012; Saygin et al., 2002; Spivak et al., 2006; Tucker et al., 2003) are detailed in Table 5.”
BackgroundAttari, A., Rajabi, F., & Maracy, M. R. (2014) · PubMed Central · Cited by 32
Li, W., Ma, Y., Yang, Q., Li, B., Meng, Q.-G., & Zhang, Y. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1291838 · Cited by 30 · cited 5×
“In comparison to our previous review, three new studies are notable for their impact and innovation; Li et al. (2017), Villarreal et al. (2016) and Feder et al. (2014).”
BackgroundResultInfluentialBaclofen Add-on to Citalopram in Treatment of Posttraumatic Stress Disorder
Manteghi, A. A., Hebrani, P., Morteza-Nia, M., Haghighi, M. B., & Javanbakht, A. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000089 · Cited by 27
Akuchekian, S., & Amanat, S. (2004) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 22
Nefazodone versus sertraline in the treatment of posttraumatic stress disorder
Saygın, M. Z., Sungur, M. Z., Sabol, E. U., & Çetinkaya, P. D. (2002) · Psychiatry and Clinical Psychopharmacology · Cited by 18
521. A randomized, controlled trial of risperidone for psychotic features in PTSD
Hamner, M. B., Ulmer, H. G., Faldowski, R. A., Frueh, B. C., TWOMEY, T. J., Tyson, C., Lorberbaum, J. P., Tenebäck, C. C., Huber, M. G., & Arana, G. W. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00791-5 · Cited by 14 · cited 5×
“Six studies assessed risperidone (Bartzokis et al., 2005; Hamner et al., 2000; Krystal et al., 2011; Monnelly et al., 2003; Reich et al., 2004; Rothbaum et al., 2008), three assessed topiramate (Akuchekian & Amanat, 2004; Batki et al., 2014; Lindley et al., 2007), and two assessed d-cycloserine…”
BackgroundInfluentialFailed efficacy of ziprasidone in the treatment of post-traumatic stress disorder
Ramaswamy, S., Driscoll, D., Smith, L. M., Bhatia, S. C., & Petty, F. (2015) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2015.12.003 · Cited by 13 · cited 3×
“…& Javanbakht, 2014; Monnelly, Ciraulo, Knapp, & Keane, 2003; Naylor et al., 2015; Neylan et al., 2006; Petrakis et al., 2016; Pollack et al., 2011; Ramaswamy, Driscoll, Smith, Bhatia, & Petty, 2016; Raskind et al., 2018, 2007; Raskind, Peskind, Kanter, Petrie, & Radant, 2003; Raskind et al.,…”
BackgroundOmranifard, V., Akochekian, S., & Amanat, S. (2006) · Annals of General Psychiatry · doi:10.1186/1744-859x-5-s1-s225 · Cited by 3
Research works printed but not linked: 8
- 32. Ferry, F., Bolton, D., Bunting, B., Devine, B., McCann, S., & Murphy, S. (2008). Trauma, health and conflict in Northern Ireland: A study of the epidemiology of trauma related disorders and qualitative investigation of the impact of trauma on the individual. Ireland: Psychology Research Institute, University of Ulster.
- 35. Forman-Hoffman, V., Middleton, J. C., Feltner, C., Gaynes, B. N., Weber, R. P., Bann, C., … Green, J. (2018b). Psychological and pharmacological treatments for adults with posttraumatic stress disorder: A systematic review update, agency for healthcare research and quality. PMID: 30204376.
- 45. Higgins, J. P. T., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions version 5.1.0. UK: The Cochrane Collaboration and John Wiley and Sons Ltd.
- 68. National Institute for Health and Care Excellence Guideline: Post-traumatic stress disorder. (2018, June). Draft for consultation. UK: NICE.
- 87. Review Manager (RevMan) (2014) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration.
- 97. SKB627, Bryson, H., Lawrinson, S., GJ, E., & KM, G. (unpublished). A 12 week, double-blind, placebo-controlled, parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from posttraumatic stress disorder.
- 98. SKB650, Bryson, H., KE, D., & Jeffery, P. J. (unpublished). A study of the maintained efficacy and safety of paroxetine versus placebo in the long-term treatment of posttraumatic stress disorder.
- 99. Sonne, S. C., Waldrop, A., Back, S., Killeen, T., McRae, A., & Brady, K. (2006) Paxil CR versus placebo in the treatment of outpatients with comorbid PTSD and substance dependence, Proceedings of the 68th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 17-22; Scottsdale, Arizona.
Cited by
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Burback, L., Brémault-Phillips, S., Nijdam, M. J., McFarlane, A., & Vermetten, E. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230428091433 · Cited by 208
Prevention and treatment of PTSD: the current evidence base
Bisson, J. I., & Olff, M. (2021) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1824381 · Cited by 150
“Pharmacological treatment of adults with PTSD (Hoskins et al., 2020).”
Self-citationBrewin, C. R., Atwoli, L., Bisson, J. I., Galea, S., Koenen, K. C., & Lewis‐Fernández, R. (2025) · World Psychiatry · doi:10.1002/wps.21269 · Cited by 142
“Most guidelines do not consider augmentation, although systematic reviews and meta-analyses provide some evidence to support augmentation of either SSRIs or venlafaxine with the alpha1-adrenoceptor antagonist prazosin 364 .”
Self-citationAstill Wright, L., Horstmann, L., Holmes, E. A., & Bisson, J. I. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01570-w · Cited by 97
Self-citationPost-traumatic Stress Disorder
Merians, A. N., Spiller, T. R., Harpaz‐Rotem, I., Krystal, J. H., & Pietrzak, R. H. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.04.003 · Cited by 129
Metadata
- Authors
- Hoskins, M. D., Bridges, J., Sinnerton, R., Nakamura, A., Underwood, J. F. G., Slater, A., Lee, M. R. D., Clarke, L., Lewis, C., Roberts, N. P., & Bisson, J. I.
- Affiliations
- Cardiff University (GB)
- Corresponding author
- Hoskins, Mathew D.
- Venue
- European Journal of Psychotraumatology
- Publisher
- Informa UK Limited
- Published
- 2021-01
- Volume
- 12
- Issue
- 1
- Pages
- 1802920-1802920
- ISSN
- 2000-8066 (ISSN-L)
- PMC
- PMC8725683
- OpenAlex
- W3123716570
- Cited by
- 127
- References
- 115
- Citations by year
- 2026: 23 · 2025: 32 · 2024: 27 · 2023: 22 · 2022: 16 · 2021: 6
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- European Journal of Psychotraumatology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The International Society for Traumatic Stress Studies
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Social Sciences › Psychology › Clinical Psychology › Migration, Health and Trauma
- Keywords
- post-traumatic stress disorder, pharmacotherapy, monotherapy, augmentation therapy, fluoxetine, paroxetine, sertraline, venlafaxine, quetiapine, prazosin, risperidone, symptom severity, head-to-head comparison
- MeSH terms
- Drug Synergism, Drug Therapy, Combination, Humans, Stress Disorders, Post-Traumatic, Antipsychotic Agents, Selective Serotonin Reuptake Inhibitors, Adrenergic alpha-1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.